Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Revenue

Mankind Pharma had revenue of 35.67B INR in the quarter ending December 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 139.14B, up 19.53% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.

• Revenue (ttm): 139.14B
• Revenue Growth: +19.53%
• P/S Ratio: 7.21
• Revenue / Employee: 7.09M
• Employees: 19,620
• Market Cap: 1.00T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	122.07B	19.47B	18.98%
Mar 31, 2024	102.60B	15.11B	17.27%
Mar 31, 2023	87.49B	9.68B	12.44%
Mar 31, 2022	77.82B	15.67B	25.22%
Mar 31, 2021	62.14B	3.43B	5.83%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error